DB00002 | Cetuximab | approved | unknown | | Details |
DB00005 | Etanercept | approved, investigational | unknown | | Details |
DB00028 | Immune Globulin Human | approved, investigational | yes | antagonist | Details |
DB00054 | Abciximab | approved | unknown | | Details |
DB00056 | Gemtuzumab ozogamicin | approved, investigational | unknown | | Details |
DB00072 | Trastuzumab | approved, investigational | unknown | | Details |
DB00074 | Basiliximab | approved, investigational | unknown | | Details |
DB00075 | Muromonab | approved, investigational | unknown | | Details |
DB00078 | Ibritumomab tiuxetan | approved, investigational | unknown | | Details |
DB00081 | Tositumomab | approved, investigational | unknown | | Details |
DB00087 | Alemtuzumab | approved, investigational | unknown | | Details |
DB00092 | Alefacept | approved, investigational, withdrawn | unknown | | Details |
DB00095 | Efalizumab | approved, investigational | unknown | | Details |
DB00108 | Natalizumab | approved, investigational | unknown | | Details |
DB00110 | Palivizumab | approved, investigational | unknown | | Details |
DB00111 | Daclizumab | investigational, withdrawn | unknown | | Details |
DB00112 | Bevacizumab | approved, investigational | unknown | | Details |
DB00098 | Antithymocyte immunoglobulin (rabbit) | approved | yes | | Details |
DB11767 | Sarilumab | approved, investigational | unknown | unknown | Details |